Trypanosoma brucei Glycogen Synthase Kinase-3, A Target for Anti-Trypanosomal Drug Development: A Public-Private Partnership to Identify Novel Leads

Richard O. Oduor; Kayode K. Ojo; Gareth P. Williams; Francois Bertelli; James Mills; Louis Maes; David C. Pryde; Tanya Parkinson; Wesley C. Van Voorhis; Tod P. Holler

doi:10.1371/journal.pntd.0001017

Loading metrics

Open Access

Peer-reviewed

Research Article

Trypanosoma brucei Glycogen Synthase Kinase-3, A Target for Anti-Trypanosomal Drug Development: A Public-Private Partnership to Identify Novel Leads

Richard O. Oduor,

Current address: Department of Biochemistry and Biotechnology, Kenyatta University, Nairobi, Kenya

Affiliation Opportunities for Partnering in Medicine, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
⨯
Kayode K. Ojo,

Affiliation Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, United States of America
⨯
Gareth P. Williams,

Affiliation High Throughput Screening Center of Emphasis, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
⨯
Francois Bertelli,

Affiliation High Throughput Screening Center of Emphasis, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
⨯
James Mills,

Affiliation Worldwide Medicinal Chemistry, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
⨯
Louis Maes,

Affiliation Laboratory for Microbiology, Parasitology and Hygiene, University of Antwerp, Antwerp, Belgium
⨯
David C. Pryde,

Affiliation Worldwide Medicinal Chemistry, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
⨯
Tanya Parkinson ,

* E-mail: tanya.parkinson@pfizer.com

Affiliation Opportunities for Partnering in Medicine, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
⨯
Wesley C. Van Voorhis,

Affiliation Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, United States of America
⨯
Tod P. Holler

Current address: Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan, United States of America

Affiliation Opportunities for Partnering in Medicine, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
⨯

Trypanosoma brucei Glycogen Synthase Kinase-3, A Target for Anti-Trypanosomal Drug Development: A Public-Private Partnership to Identify Novel Leads

Richard O. Oduor,
Kayode K. Ojo,
Gareth P. Williams,
Francois Bertelli,
James Mills,
Louis Maes,
David C. Pryde,
Tanya Parkinson,
Wesley C. Van Voorhis,
Tod P. Holler

Published: April 5, 2011
https://doi.org/10.1371/journal.pntd.0001017

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Drug discovery
Is the Subject Area "Drug discovery" applicable to this article?

Thanks for your feedback.
African trypanosomiasis
Is the Subject Area "African trypanosomiasis" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Drug screening
Is the Subject Area "Drug screening" applicable to this article?

Thanks for your feedback.
Parasitic diseases
Is the Subject Area "Parasitic diseases" applicable to this article?

Thanks for your feedback.
Enzyme inhibitors
Is the Subject Area "Enzyme inhibitors" applicable to this article?

Thanks for your feedback.
Trypanosoma brucei gambiense
Is the Subject Area "Trypanosoma brucei gambiense" applicable to this article?

Thanks for your feedback.
Glycogens
Is the Subject Area "Glycogens" applicable to this article?

Thanks for your feedback.